Indoco Remedies (NSE: INDOCO) is a leading Indian pharmaceutical company that operates in both domestic and international markets. The company has a diverse product portfolio that includes prescription drugs, over-the-counter (OTC) medicines, and veterinary products. Indoco Remedies has a strong presence in India and operates in more than 80 countries worldwide.
Quarterly Earnings Summary:
- Indoco Remedies reported a consolidated revenue of ₹411.15 crore for Q3 FY 2023, an increase of 18% compared to the same quarter of the previous year.
- The company’s net profit for Q3 FY 2023 stood at ₹28.14 crore, a decline from Net Profit of ₹33 crore in the same quarter of the previous year.
- The company’s domestic business recorded a growth of 11%, while the international business grew by 26% during the quarter.
- The Earnings Per Share was ₹3.05 for this quarter.